Researchers Improve Accuracy of Molecular Imaging for Cancer Patients
By MedImaging International staff writers Posted on 22 Jun 2016 |
Image: A patient undergoing a positron emission tomography (PET) scan (Photo courtesy of Wellcome Images).
Researchers have unveiled a new method that enables clinicians to measure Lean Body Mass (LBM) for cancer patients, and improve staging of the cancer, and help monitor therapy.
The new Computed Tomography (CT) procedure enables clinicians to obtain accurate LBM measurements and more precise molecular imaging results. The technique for measuring LBM can take into account changes in individual body composition.
Researchers from the University of Alberta Edmonton (Alberta, Canada) presented the information in a scientific paper at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2016) in San Diego, California, USA.
Clinicians routinely use positron emission tomography (PET) together with a radiotracer to find areas where there are abnormal increases in metabolic activity. The increase is measured using Standardized Uptake Values (SUV). The SUVs of radiotracer tumors are currently measured using the overall weight of a cancer patient, but this can change significantly during treatment, and can result in significant over or under-estimation of the LBM. The new CT method can measure patient-specific LBM much more accurately, and is called SULps.
Principal author of the study, Alexander McEwan, MD, University of Alberta Edmonton, said, "Patients with advanced cancer tend to lose muscle and may gain fat, and these changes in body composition can significantly modify PET results, independent of the actual metabolic activity of the tumor. Our study shows that CT-derived SULps is a more robust measurement for patients with advanced cancer undergoing PET imaging. If adopted, this simple change in imaging protocol could lead to significantly more effective care for cancer patients."
Related Links:
University of Alberta Edmonton
The new Computed Tomography (CT) procedure enables clinicians to obtain accurate LBM measurements and more precise molecular imaging results. The technique for measuring LBM can take into account changes in individual body composition.
Researchers from the University of Alberta Edmonton (Alberta, Canada) presented the information in a scientific paper at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2016) in San Diego, California, USA.
Clinicians routinely use positron emission tomography (PET) together with a radiotracer to find areas where there are abnormal increases in metabolic activity. The increase is measured using Standardized Uptake Values (SUV). The SUVs of radiotracer tumors are currently measured using the overall weight of a cancer patient, but this can change significantly during treatment, and can result in significant over or under-estimation of the LBM. The new CT method can measure patient-specific LBM much more accurately, and is called SULps.
Principal author of the study, Alexander McEwan, MD, University of Alberta Edmonton, said, "Patients with advanced cancer tend to lose muscle and may gain fat, and these changes in body composition can significantly modify PET results, independent of the actual metabolic activity of the tumor. Our study shows that CT-derived SULps is a more robust measurement for patients with advanced cancer undergoing PET imaging. If adopted, this simple change in imaging protocol could lead to significantly more effective care for cancer patients."
Related Links:
University of Alberta Edmonton
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment